{
    "clinical_study": {
        "@rank": "119340", 
        "acronym": "SELECT-LV", 
        "arm_group": {
            "arm_group_label": "Implant", 
            "arm_group_type": "Experimental", 
            "description": "Implant of the WiCS-LV system"
        }, 
        "brief_summary": {
            "textblock": "The study is intended to demonstrate the safe implant of small receiver-electrodes into the\n      endocardial surface of the left ventricle and to demonstrate its utility in providing\n      cardiac resynchronization therapy in heart failure patients."
        }, 
        "brief_title": "Safety and Performance of Electrodes Implanted in the Left Ventricle", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Heart Failure", 
            "Ventricular Dysfunction", 
            "Cardiomyopathies", 
            "Heart Diseases", 
            "Cardiovascular Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Heart Diseases", 
                "Heart Failure", 
                "Ventricular Dysfunction", 
                "Cardiomyopathies"
            ]
        }, 
        "detailed_description": {
            "textblock": "Eligible patients will undergo an acoustic window assessment using transthoracic\n      echocardiography. Patients with adequate acoustic windows will undergo implantation of the\n      WiCS-LV system.\n\n      Patients will undergo evaluations pre-hospital discharge, and at one month, 3 months, and 6\n      months post implantation. Extended follow-up will be obtained via a registry at 1, 2, 3, 4,\n      and 5 years post implantation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Patients with standard indications for CRT based upon the most recent ESC/EHRA guidelines\n        AND meeting criteria for one of these two categories:\n\n          1. Patients with previously implanted pacemakers or ICD's and meeting standard\n             indications for CRT but in whom  standard CRT is not advisable due to known high risk\n             -  referred to as \"upgrades\".  Justifications for not using standard CRT must be\n             documented in a CRF.\n\n          2. Patients in whom coronary sinus lead implantation or attempted implantation for CRT\n             has failed to provide demonstrable therapy benefit - referred to as \"untreated\"\n\n        Exclusion Criteria:\n\n          1. Inability to comply with the study follow-up or other study requirements\n\n          2. History of chronic alcohol/drug abuse and currently using alcohol/drugs\n\n          3. Non-ambulatory (or unstable) NYHA class 4\n\n          4. Contraindication to heparin\n\n          5. Contraindication to both chronic anticoagulants and antiplatelet agents\n\n          6. Triple anticoagulation therapy (warfarin, clopidogrel, ASA, and other agents)\n\n          7. Thrombocytopenia (platelet count <150,000)\n\n          8. Contraindication to iodinated contrast agents\n\n          9. Intracardiac thrombus by transesophageal echocardiography\n\n         10. Age less than 18 years or greater than 75\n\n         11. Attempted IPG implant within 3 days\n\n         12. Life expectancy of less than 12 months\n\n         13. Chronic hemodialysis\n\n         14. Stage 4 or 5 renal dysfunction defined as GFR <30\n\n         15. Grade 4 mitral valve regurgitation\n\n         16. Myocardial infarction within one month\n\n         17. Major cardiac surgery within one month\n\n         18. History of a pericardial effusion in prior procedures\n\n         19. Female of childbearing potential, pregnant, or breastfeeding (a pregnancy test will\n             be obtained where applicable)\n\n         20. Non-cardiac implanted electrical stimulation therapy devices"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01905670", 
            "org_study_id": "EBR-02494", 
            "secondary_id": "CIV-13-04-010803"
        }, 
        "intervention": {
            "arm_group_label": "Implant", 
            "description": "Wireless cardiac stimulator implant to pace the left ventricle for CRT Transvascular endocardial implantation of wireless pacing Electrode and subcutaneous implantation of Implantable Pulse Generator", 
            "intervention_name": "WiCS-LV system", 
            "intervention_type": "Device", 
            "other_name": "Implant"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cardiac Resynchronization Therapy", 
            "cardiac pacing", 
            "electrical stimulation", 
            "bi-ventricular pacing"
        ], 
        "lastchanged_date": "October 18, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Petr Neu\u017eil, M.D., Ph.D.", 
                    "phone": "+420 257 272 221"
                }, 
                "facility": {
                    "address": {
                        "city": "Prague", 
                        "country": "Czech Republic", 
                        "zip": "150 30"
                    }, 
                    "name": "Na Homolce Hospital"
                }, 
                "investigator": {
                    "last_name": "Petr Neu\u017eil, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sar@rn.dk", 
                    "last_name": "Sam Riahi, MD", 
                    "phone": "+45-99322177"
                }, 
                "facility": {
                    "address": {
                        "city": "Aalborg", 
                        "country": "Denmark", 
                        "zip": "9100"
                    }, 
                    "name": "Aalborg University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Sam Riahi, MD, PhD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Peter Sogaard, MD, DMSc", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Czech Republic", 
                "Denmark"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "Multicenter, Prospective Evaluation of Safety and Performance of the WiCS-LV System in Patients Indicated for Cardiac Resynchronization Therapy", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Czech Republic: State Institute for Drug Control", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Device-related adverse events are those in which the WiCS-LV system is directly or indirectly responsible.", 
                "measure": "Number of patients with device-related adverse events as a measure of safety", 
                "safety_issue": "Yes", 
                "time_frame": "24 hour peri-operative and one month"
            }, 
            {
                "description": "Procedure-related adverse events are those which occur during the WiCS-LV system implant procedure.", 
                "measure": "Number of patients with procedure-related adverse events as a measure of safety", 
                "safety_issue": "Yes", 
                "time_frame": "24 hour perioperative and one month"
            }, 
            {
                "description": "Bi-ventricular pacing capture documented on 12-lead EKG", 
                "measure": "Bi-ventricular pacing capture", 
                "safety_issue": "No", 
                "time_frame": "one month"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01905670"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Device-related adverse events are those in which the WiCS-LV system is directly or indirectly responsible.", 
                "measure": "Number of patients with device-related adverse events as a measure of safety", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "Number of patients with serious adverse events as a measure of safety", 
                "safety_issue": "Yes", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Bi-ventricular pacing capture documented on 12-lead EKG", 
                "measure": "Bi-ventricular pacing capture", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Composite of all cause mortality, heart failure hospitalization, NYHA class, and patient global assessment", 
                "measure": "Clinical composite score", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "change in left-ventricular end-systolic volume, left ventricular end-diastolic volume, and ejection fraction", 
                "measure": "Change in echocardiographic indices", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "EBR Systems, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "EBR Systems, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}